In Brief:
A retrospective analysis of 182 breast reductions disclosed 19 with proliferative changes, including five with atypia, three with sclerosing adenosis, one with papillomatosis, and one with lobular carcinoma in situ. Fifteen per cent of women aged 30–39 showed proliferative changes, higher than previously reported for this age group.